Abivax (ABVX) Prepaid Assets (2022 - 2026)
Abivax (ABVX) recorded quarterly Prepaid Assets of $16.1 million in Q1 2026, up 5.34% quarter-over-quarter from $15.3 million in Q4 2025, and down 28.95% on a YoY basis from $22.7 million in Q1 2025.
Abivax (ABVX) Prepaid Assets (2022 - 2026) Analysis & Trends
Abivax's Prepaid Assets history runs 5 years deep, the most recent figure standing at $16.1 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 28.95% year-over-year to $16.1 million; the TTM figure through Mar 2026 stood at $16.1 million (down 28.95% YoY), while the FY2025 annual figure was $15.3 million, down 45.77% from the prior year.
- Prepaid Assets was $16.1 million for Q1 2026 at Abivax, up from $15.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $28.2 million in Q4 2024 to a low of $933526.3 in Q4 2022.
- Historically, Prepaid Assets has averaged $17.2 million across 5 years, with a median of $19.4 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets soared 562.26% in 2023, then tumbled 45.77% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $933526.3 in 2022, then jumped by 562.26% to $6.2 million in 2023, then surged by 356.31% to $28.2 million in 2024, then sank by 45.77% to $15.3 million in 2025, then rose by 5.34% to $16.1 million in 2026.
- The last three Prepaid Assets figures came in at $16.1 million (Q1 2026), $15.3 million (Q4 2025), and $23.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.12 Mn |
| Dec 31, 2025 | 15.30 Mn |
| Sep 30, 2025 | 23.87 Mn |
| Jun 30, 2025 | 19.40 Mn |
| Mar 31, 2025 | 22.68 Mn |
| Dec 31, 2024 | 28.21 Mn |
| Jun 30, 2024 | 22.11 Mn |
| Dec 31, 2023 | 6.18 Mn |
| Dec 31, 2022 | 933,526.34 |